申请人:HOKURIKU SEIYAKU CO., LTD.
公开号:EP1104764A1
公开(公告)日:2001-06-06
1H-Imidazopyridine derivatives represented by the following general formula or salts thereof:
wherein R1 represents hydrogen atom, hydroxyl group, an alkyl group, a cycloalkyl group, styryl group, or an aryl group; R2 represents hydrogen atom, an alkyl group, a halogen atom, hydroxyl group, amino group, a cyclic amino group, or phenoxy group; ring A represents a homocyclic or heterocyclic ring which may be substituted; R3 represents a saturated nitrogen-containing heterocyclic group; and m represents an integer of from 0 to 3. The derivatives have excellent inhibitory actions against production of TNF or IL-1 and are extremely useful as preventive or therapeutic agents for diseases in which a cytokine is mediated.
由以下通式代表的 1H-咪唑吡啶衍生物或其盐:
其中 R1 代表氢原子、羟基、烷基、环烷基、苯乙烯基或芳基;R2 代表氢原子、烷基、卤素原子、羟基、氨基、环氨基或苯氧基;环 A 代表可被取代的同环或杂环;R3 代表饱和含氮杂环基;m 代表 0 至 3 的整数。这些衍生物对 TNF 或 IL-1 的产生具有极佳的抑制作用,可作为细胞因子介导的疾病的预防或治疗药物。